Skip to Content
Merck
  • Comprehensive Mapping of Key Regulatory Networks that Drive Oncogene Expression.

Comprehensive Mapping of Key Regulatory Networks that Drive Oncogene Expression.

Cell reports (2020-11-26)
Lin Lin, Benjamin Holmes, Max W Shen, Darnell Kammeron, Niels Geijsen, David K Gifford, Richard I Sherwood
ABSTRACT

Gene expression is controlled by the collective binding of transcription factors to cis-regulatory regions. Deciphering gene-centered regulatory networks is vital to understanding and controlling gene misexpression in human disease; however, systematic approaches to uncovering regulatory networks have been lacking. Here we present high-throughput interrogation of gene-centered activation networks (HIGAN), a pipeline that employs a suite of multifaceted genomic approaches to connect upstream signaling inputs, trans-acting TFs, and cis-regulatory elements. We apply HIGAN to understand the aberrant activation of the cytidine deaminase APOBEC3B, an intrinsic source of cancer hypermutation. We reveal that nuclear factor κB (NF-κB) and AP-1 pathways are the most salient trans-acting inputs, with minor roles for other inflammatory pathways. We identify a cis-regulatory architecture dominated by a major intronic enhancer that requires coordinated NF-κB and AP-1 activity with secondary inputs from distal regulatory regions. Our data demonstrate how integration of cis and trans genomic screening platforms provides a paradigm for building gene-centered regulatory networks.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hydroxyurea, 98%, powder
Sigma-Aldrich
Imidazolo-oxindole PKR inhibitor C16, ≥98% (HPLC)
Sigma-Aldrich
BX-795 hydrochloride, ≥98% (HPLC)
Sigma-Aldrich
U0126, U0126, CAS 109511-58-2, is a potent and specific inhibitor of MEK1 (IC₅₀ = 72 nM) and MEK2 (IC₅₀ = 58 nM). The inhibition is noncompetitive with respect to both ATP and ERK.
Sigma-Aldrich
Gemcitabine hydrochloride, ≥98% (HPLC)
Sigma-Aldrich
Y-27632-CAS 331752-47-7-Calbiochem, Y-27632A, CAS 331752-47-7, is a cell-permeable, reversible, inhibitor of Rho kinases (Ki = 140 nM for p160ROCK). Enhances survival & cloning efficiency of ESC without affecting their pluripotency.